Chemoinformaics analysis of 1-pentylcyclohexa-1,3-diene
| Molecular Weight | 150.265 | nRot | 4 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 6 |
| Exact Molecular Weight | 150.141 | nRing | 1 |
| Solubility: LogS | -3.907 | nHRing | 0 |
| Solubility: LogP | 4.057 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.3723 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.534 |
| Synth | 2.615 |
| Natural Product Likeliness | 1.685 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.636 |
| Pgp-sub | 0.046 |
| HIA | 0.003 |
| CACO-2 | -4.567 |
| MDCK | 0.0000155 |
| BBB | 0.692 |
| PPB | 0.9563 |
| VDSS | 3.628 |
| FU | 0.0437 |
| CYP1A2-inh | 0.769 |
| CYP1A2-sub | 0.851 |
| CYP2c19-inh | 0.342 |
| CYP2c19-sub | 0.897 |
| CYP2c9-inh | 0.194 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.528 |
| CYP2d6-sub | 0.88 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.305 |
| CL | 0.838 |
| T12 | 0.59 |
| hERG | 0.145 |
| Ames | 0.019 |
| ROA | 0.077 |
| SkinSen | 0.963 |
| Carcinogencity | 0.736 |
| EI | 0.979 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.832875 |